Exosomes are nanosized extracellular vesicles (30 - 150 nm) released by virtually all cell types and recognized as critical mediators of intercellular communication. They transport functional biomolecules - including proteins, mRNA, miRNA, and lipids - to target cells, influencing pathways involved in tissue regeneration, immune regulation, inflammation, and disease progression. Owing to their natural biocompatibility, stability, and specificity, exosomes have become an important focus in biomarker discovery, drug delivery, and therapeutic development.

This product contains purified exosomes isolated from Jurkat cells, an immortalized human CD4⁺ T-cell line. Exosomes were prepared from Jurkat cell culture supernatant by sequential centrifugation, polymer precipitation, and size-exclusion chromatography (SEC). Purified exosomes are formulated and stored in 0.05 µm (50 nm)-filtered PBS containing 5% trehalose and protease inhibitor cocktail.

Exosomes were characterized by flow cytometry to confirm expression of universal exosome markers CD9, CD63, and CD81, as well as additional cell-specific markers. For Jurkat-derived exosomes specifically, CD9, CD63, CD81, CD3, CD4, and CD45 were analyzed. As shown in Figure 1, exosomes showed strong expression of CD9, CD81, and CD3.

Exosomes are supplied at 50 µg per vial, with the exosome particle count indicated on the vial label. Exosomes were prepared under physiological conditions to preserve native bioactivity and are suitable for both in vitro and in vivo functional studies.